ABSTRACT
This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.
Subject(s)
Atrial Fibrillation , Factor Xa Inhibitors , Rivaroxaban , Uterine Hemorrhage , Humans , Rivaroxaban/adverse effects , Female , Adult , Factor Xa Inhibitors/adverse effects , Factor Xa Inhibitors/therapeutic use , Uterine Hemorrhage/chemically induced , Atrial Fibrillation/drug therapy , Leiomyoma/drug therapy , Menorrhagia/chemically induced , Menorrhagia/drug therapy , Uterine Neoplasms/drug therapyABSTRACT
Women suffering from chronic vulvar pain seek help in the healthcare system on numerous occasions. The most common type is provoked localized vulvodynia (PVD) in which the pain has been persistent for more than three months without identifiable cause. The aetiology of PVD is multifactorial and the diagnosis is based upon medical history and gynaecological assessment including a bio-psycho-social evaluation. Danish and international guidelines point to the advantages of a multidisciplinary approach, where physical, psycho-sexual assessment is integrated in a multidisciplinary treatment programme as summarized in this review.
Subject(s)
Vulvodynia , Female , Humans , Pain , Pain Measurement , Sexual Behavior , Surveys and Questionnaires , Vulvodynia/diagnosis , Vulvodynia/etiology , Vulvodynia/therapyABSTRACT
This is a case report of multiple uterine lithiasis in a 66-year-old, healthy woman. The patient had postmenopausal bleeding but no other complaints. She underwent uneventful vaginal hysterectomy, and multiple loose pieces of detached uterine lithiasis in the uterine cavity were found. It is very rare to find stones in the human uterus without any intrauterine device, neoplasia or malignancy.